当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Fairclough Foud
This abstract provides an overview of a study comparing expressed drug use, as self-reported by individuals, with
actual test results. The research aims to investigate the accuracy and reliability of self-reported drug use compared
to objective testing methods, such as urinalysis or blood tests. The study incorporates diverse populations, spanning
different demographics and drug use histories, to ensure a comprehensive analysis of the correlation between selfdisclosed
drug use and laboratory results. The research methodology involves collecting self-reported data through
surveys or interviews, where participants provide information about their drug use patterns, frequency, and types of
substances used. Concurrently, objective drug testing measures are administered to obtain accurate and verifiable
results. The study carefully examines the discrepancies, if any, between self-reported drugs use and the actual test
outcomes. Furthermore, the abstract explores potential factors influencing the accuracy of self-reported drug use,
including social desirability bias, memory recall, and the reluctance to disclose sensitive information. By identifying
these factors, the study aims to enhance the understanding of the limitations associated with self-reported drug use
data. The implications of the research extend to various fields, including clinical settings, substance abuse treatment
programs, and public health initiatives. Accurate information about drug use is essential for designing effective
interventions, developing targeted prevention strategies, and evaluating the success of treatment programs. The
findings of this study contribute valuable insights into the reliability of self-reported drug use data, informing best
practices for obtaining accurate information and improving the overall validity of substance use research.